Alpha 2.0
Login Register
» Articles » PMID: 32389843

Re: 'Colistin Plus Meropenem for Carbapenem-resistant Gram-negative Infections: In vitro Synergism is Not Associated with Better Clinical Outcomes' by Nutman Et al

Overview
Journal Clin Microbiol Infect
Publisher Elsevier
Specialty Infectious Diseases
Date 2020 May 12
PMID 32389843
Citations 3
Authors
S Karakonstantis
Affiliations
Soon will be listed here.
Citing Articles

In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations.

Karakonstantis S, Ioannou P, Kofteridis D Infection. 2022; 50(3):569-581.

PMID: 34982411 DOI: 10.1007/s15010-021-01748-w.

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant .

Karakonstantis S, Ioannou P, Samonis G, Kofteridis D Antibiotics (Basel). 2021; 10(11).

PMID: 34827282 PMC: 8615225. DOI: 10.3390/antibiotics10111344.

Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.

Karakonstantis S, Kritsotakis E, Gikas A Infection. 2020; 48(6):835-851.

PMID: 32875545 PMC: 7461763. DOI: 10.1007/s15010-020-01520-6.